This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.ES Ford , UA Ajani , JB Croft (2007) Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med 356, 2388–2398.
4.ES Ford , SJ Smith , DF Stroup (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case–control studies and nested case–control studies. Int J Epidemiol 31, 59–70.
5.NJ Wald , HC Watt , MR Law (1998) Homocysteine and ischaemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 158, 862–867.
9.J Ishihara , H Iso , M Inoue (2008) Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Centre-based Prospective Study Cohort I. J Am Coll Nutr 27, 127–136.
10.EB Rimm , WC Willett , FB Hu (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279, 359–364.
11.A Tavani , C Pelucchi , M Parpinel (2004) Folate and vitamin B(6) intake and risk of acute myocardial infarction in Italy. Eur J Clin Nutr 58, 1266–1272.
12.G Schnyder , M Roffi , R Pin (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345, 1593–1600.
13.G Schnyder , M Roffi , Y Flammer (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomised controlled trial. JAMA 288, 973–979.
14.LA Bazzano , K Reynolds , KN Holder (2006) Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomised controlled trials. JAMA 296, 2720–2726.
15.KH Bønaa , I Njølstad , PM Ueland (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 1578–1588.
16.M Ebbing , Ø Bleie , PM Ueland (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomised controlled trial. JAMA 300, 795–804.
17.J Muntwyler , CH Hennekens , JE Manson (2002) Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 162, 1472–1476.
18.CM Albert , NR Cook , JM Gaziano (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomised trial. JAMA 299, 2027–2036.
20.Q Yang , LD Botto , JD Erickson (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 1335–1343.
22.LA Bazzano , J He , LG Ogden (2002) Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke 33, 1183–1188.
23.V Sepe , G Adamo , MG Giuliano (2007) Folic acid for stroke prevention – author reply 651. Lancet 370, 651.
24.JK Virtanen , S Voutilainen , P Happonen (2005) Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Eur J Cardiovasc Prev Rehabil 12, 369–375.
25.X Wang , X Qin , H Demirtas (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876–1882.
26.K Radimer , B Bindewald , J Hughes (2004) Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000. Am J Epidemiol 160, 339–349.
29.DE Nelson , E Powell-Griner , M Town (2003) A comparison of national estimates from the National Health Interview Survey and the Behavioural Risk Factor Surveillance System. Am J Public Health 93, 1335–1341.
30.J Satia-Abouta , RE Patterson , IB King (2003) Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol 157, 944–954.
31.TL Bush , SR Miller , AL Golden (1989) Self-report and medical records report agreement of selected medical conditions in the elderly. Am J Public Health 79, 1554–1556.
32.Y Okura , LH Urban , DW Mahoney (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57, 1096–1103.
33.J Satia-Abouta , AR Kristal , RE Patterson (2003) Dietary supplement use and medical conditions: the VITAL study. Am J Prev Med 24, 43–51.
34.C Buettner , RS Phillips , RB Davis (2007) Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am J Cardiol 99, 661–666.
35.A Liem , GH Reynierse-Buitenwerf , AH Zwinderman (2005) Secondary prevention with folic acid: results of the Goes extension study. Heart 91, 1213–1214.
36.JF Toole , MR Malinow , LE Chambless (2004) Lowering homocysteine in patients with ischaemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomised controlled trial. JAMA 291, 565–575.
37.AL Moens , CJ Vrints , MJ Claeys (2008) Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 294, H1971–H1977.
38.C Fernandez-Miranda , M Yebra , JL Aranda (2007) Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease. Int J Cardiol 118, 345–349.
39.G Ntaios , C Savopoulos , A Hatzitolios (2009) Is there a beneficial effect of folic acid on carotid intima-media thickness? Int J Cardiol 135, 260–261.
40.K Potter , GJ Hankey , DJ Green (2008) The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomised controlled trial and meta-analysis. BMC Cardiovasc Disord 8, 24–37.
41.U Till , P Rohl , A Jentsch (2005) Decrease of carotid intima-media thickness in patients at risk to cerebral ischaemia after supplementation with folic acid, vitamins B6 and B12. Atherosclerosis 181, 131–135.
42.P Poredos (2004) Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis. Vasc Med 9, 46–54.
43.C Antoniades , C Shirodaria , N Warrick (2006) 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114, 1193–1201.
45.C Shirodaria , C Antoniades , J Lee (2007) Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 115, 2262–2270.
46.A Tawakol , RQ Migrino , KS Aziz (2005) High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol 45, 1580–1584.
47.SN Doshi , IF McDowell , SJ Moat (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105, 22–26.
48.E Setola , LD Monti , E Galluccio (2004) Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151, 483–489.
49.LM Title , E Ur , K Giddens (2006) Folic acid improves endothelial dysfunction in type 2 diabetes – an effect independent of homocysteine-lowering. Vasc Med 11, 101–109.
50.TS Church , CP Earnest , KA Wood (2003) Reduction of C-reactive protein levels through use of a multivitamin. Am J Med 115, 702–707.